Click here - to use the wp menu builder
Search
MZP News
MZP News
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Our Team
Contact Us
About Us
Sign in / Join
15.3
C
New York
MZP News
Friday, September 29, 2023
type here...
Search
Home
Finance
Business
Companies
Technology
MZP News
Home
Finance
Business
Companies
Technology
- Advertisement -
TAG
EU
Technology
How much can investors make with enCore Energy Corp (EU) stock in the next 12 months?
Kevin Freeman
-
September 25, 2023
Currently, enCore Energy Corp is trading at $3.20, up 7.38%. In order to assess the stock's recent performance, you can check whether its...
Finance
Long-Time Horizon Analysis of enCore Energy Corp. (EU) Stock
MZP Desk
-
September 18, 2023
Currently, enCore Energy Corp. is trading at $3.03, up 2.02%. It is a good measure of the stock's recent performance to check whether...
Companies
enCore Energy Corp. (EU) Stock Up 3.46%: Is It a Good Investment?
MZP Desk
-
September 12, 2023
enCore Energy Corp. stock prices are up 3.46% to $2.69 at the moment. In order to assess the stock's recent performance, you can...
Technology
Growth and Margin Analysis of enCore Energy Corp. (EU)’s Recent Quarter Sales
Abby Carey
-
September 7, 2023
At the time of writing, enCore Energy Corp. stock is trading at $2.63, down -0.75%. It is a good measure of the stock's...
Companies
Analysts predict enCore Energy Corp. (EU) stock to reach $4.52 in the next 12 months
Kiel Thompson
-
August 24, 2023
A share price of enCore Energy Corp. is currently trading at $2.53, up 4.55%. One of the good ways to gauge the recent...
Technology
Here is how enCore Energy Corp. (EU) stock might take investors finances to the next level
Nora Barnes
-
August 11, 2023
enCore Energy Corp. stock is trading at $2.47, up 1.23%. Until recently, the best way to gauge how the stock has performed was...
Featured
Bristol-Myers Squibb’s [NYSE: BMY] Breyanzi Receives FDA Approval
MZP Desk
-
February 6, 2021
Bristol-Myers Squibb declared that FDA has awarded permission to the Breyanzi of the firm for the therapy of adult sufferers with relapsed or...
Latest news
DoubleVerify Holdings Inc (DV) Shares on the Rise: Short-term Analysis
September 28, 2023
Recent Performance of Five Below Inc (FIVE) Stock: A Closer Look
September 28, 2023
Is Green Dot Corp. (GDOT) Holding Up Well Over a Long-Time Horizon?
September 28, 2023
Coterra Energy Inc (CTRA) Shares Gain 0.82% Over Last Week
September 28, 2023
The Short-term Rise and Fall of Cytek BioSciences Inc (CTKB) Stock
September 28, 2023
- Advertisement -